Medacta Group
Medacta Group SA is a Swiss medical device manufacturer developing orthopedic implants, surgical instruments, and personalized patient-matched technologies globally. The company designs and manufactures joint replacement systems for hips, knees, shoulders, and spine, alongside personalized MyKnee and MyShoulder 3D surgical planning tools. Revenue is derived primarily from direct sales of joint implants, surgical guides, and biological fixations to hospitals and orthopedic clinics. Core end markets serve orthopedic surgeons, clinical hospitals, ambulatory surgical centers, and joint replacement patients across Europe, North America, and Asia-Pacific. Medacta Group holds an established market position in joint replacement orthopedics, pioneering minimally invasive surgical techniques and personalized 3D planning. The corporation is headquartered in Castel San Pietro, Switzerland, and its shares trade on the SIX Swiss Exchange.
4 of the funds FundTelligence covers report a position in Medacta Group.
- Legal name
- Medacta Group SA
- Sector
- Health Care
- Country
- Switzerland
- Funds holding it
- 4
- Exposure themes
- Ageing & Longevity, Healthy Ageing & Function, Mobility & Orthopaedics
Funds holding Medacta Group
- Templeton Global Smaller Companies Fund — Franklin Templeton · 1.32 % (full portfolio disclosed, September 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)
- DNB Global Enhanced Small Cap — DNB · 0.0 % (full portfolio disclosed, September 2026)